Free Trial

Deutsche Bank AG Sells 998,506 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Sabra Health Care REIT logo with Finance background

Deutsche Bank AG reduced its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 32.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,086,792 shares of the real estate investment trust's stock after selling 998,506 shares during the period. Deutsche Bank AG owned approximately 0.88% of Sabra Health Care REIT worth $36,143,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in SBRA. VSM Wealth Advisory LLC purchased a new position in Sabra Health Care REIT in the fourth quarter worth $26,000. Assetmark Inc. lifted its stake in Sabra Health Care REIT by 33.4% during the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after purchasing an additional 656 shares during the last quarter. Jones Financial Companies Lllp lifted its position in Sabra Health Care REIT by 208.3% during the 4th quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust's stock worth $108,000 after acquiring an additional 4,204 shares during the period. FIL Ltd grew its position in Sabra Health Care REIT by 40.4% during the fourth quarter. FIL Ltd now owns 6,512 shares of the real estate investment trust's stock worth $113,000 after buying an additional 1,873 shares during the period. Finally, Autumn Glory Partners LLC acquired a new stake in shares of Sabra Health Care REIT during the fourth quarter worth $173,000. Hedge funds and other institutional investors own 99.40% of the company's stock.

Sabra Health Care REIT Price Performance

NASDAQ:SBRA traded up $0.10 during trading hours on Monday, hitting $17.97. 458,841 shares of the stock were exchanged, compared to its average volume of 2,172,326. The company has a market cap of $4.27 billion, a P/E ratio of 33.91, a P/E/G ratio of 1.97 and a beta of 0.88. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The firm's fifty day moving average price is $17.49 and its 200 day moving average price is $17.41. Sabra Health Care REIT, Inc. has a 52-week low of $13.87 and a 52-week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.01. The business had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.35 earnings per share. As a group, equities research analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Shareholders of record on Friday, May 16th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, May 16th. This represents a $1.20 annualized dividend and a yield of 6.68%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 203.39%.

Analyst Ratings Changes

A number of brokerages have recently commented on SBRA. Scotiabank raised their price target on Sabra Health Care REIT from $18.00 to $19.00 and gave the company a "sector perform" rating in a report on Monday, May 12th. Truist Financial upped their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $19.50.

View Our Latest Analysis on Sabra Health Care REIT

About Sabra Health Care REIT

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Read More

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Health Care REIT Right Now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines